Transcriptomics

Dataset Information

0

Py2T long term cells and mesenchymal breast cancer cells (MTΔECad) treated with different inhibitors


ABSTRACT: Cancer cell plasticity facilitates the development of therapy resistance and malignant progression. De-differentiation processes, such as an epithelial-mesenchymal transition (EMT), are known to enhance cellular plasticity. Here, we demonstrate that cancer cell plasticity can be exploited therapeutically by forcing the trans-differentiation of EMT-derived breast cancer cells into post-mitotic and functional adipocytes. Delineation of the molecular pathways underlying such trans-differentiation has motivated a combination therapy with a MEK inhibitor and the anti-diabetic drug Rosiglitazone in various mouse models of murine and human breast cancer in vivo. This combination therapy provokes the conversion of invasive and disseminating cancer cells into post-mitotic adipocytes leading to the repression of primary tumor invasion and metastasis formation

ORGANISM(S): Mus musculus

PROVIDER: GSE118612 | GEO | 2019/01/21

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-01-23 | GSE89553 | GEO
2024-10-25 | GSE270368 | GEO
2024-10-25 | GSE262007 | GEO
2024-10-25 | GSE262001 | GEO
2023-12-23 | GSE163800 | GEO
2022-08-23 | PXD028495 | Pride
2014-03-19 | E-GEOD-53925 | biostudies-arrayexpress
2014-03-19 | E-GEOD-53923 | biostudies-arrayexpress
2015-10-12 | GSE67872 | GEO
2015-10-07 | GSE67681 | GEO